Cappagli, V. http://orcid.org/0000-0003-0726-8125
Moriconi, D.
Bonadio, A. G.
Giannese, D.
La Manna, Gaetano
Egidi, M. Francesca
Comai, G.
Vischini, G.
Bottici, V.
Elisei, R. http://orcid.org/0000-0002-5333-9257
Viola, D.
Article History
Received: 6 March 2020
Accepted: 21 April 2020
First Online: 3 May 2020
Compliance with ethical standards
:
: Elisei Rossella has been a consultant for Exelixis for cabozantinib development. However, these commitments did not have any influence on this study which has been developed independently and there was no conflict of interest in writing paper. The other authors have nothing to disclose.
: The study was approved by the Local Ethical Committee of University of Pisa.
: Informed consent was obtained from all patients to use their data for scientific purpose including this study.
: Data are available from the corresponding author on reasonable request.